Immunohistopathology to guide multiple sclerosis treatment (Q57584391)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099274%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Immunohistopathology to guide multiple sclerosis treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099274%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099274%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Ghislain Opdenakker

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099274%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099274%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099274%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

9485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099274%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

526-527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099274%20AND%20SRC:MED&resulttype=core&format=json

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

Cytokine-regulated proteases in autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

Disease-modifying Therapies for Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

Neutralizing antibodies in gene-defective hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967076-6

7 January 2021

10.1016/S0140-6736(05)67076-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16099274%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference